MF
CRMD icon

Magnetar Financial’s CorMedix CRMD Stock Holding History

Magnetar Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
+36,517
New +$288K ﹤0.01% 801

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Magnetar Financial's CRMD Position: Q2 2026 in Review

Magnetar Financial opened a new position in CorMedix (CRMD) in Q2 2026: 36,517 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #801 among its holdings.

194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Magnetar Financial held 36,517 shares of CorMedix worth $287K as of Q2 2026.
  • CorMedix was a new Magnetar Financial position in Q2 2026.
  • CorMedix made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #801 holding.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.